Name | Suvn-G3031 |
---|---|
Synonyms |
N-{4-[(1-Cyclobutyl-4-piperidinyl)oxy]phenyl}-2-(4-morpholinyl)acetamide
4-Morpholineacetamide, N-[4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl]- Suvn-G3031 |
Description | SUVN-G3031 (SUVN-G 3031) is a potent, selective, orally active histamine H3 receptor (H3R) inverse agonist with Ki of 8.73 nM (hH3R); exhibited an IC50 of 20 nM with progressive inhibition of (R)-α-methylhistamine (0.03 µM) induced agonist activity in [35S]-GTPγS binding assay using CHO-K1 cells expressing human H3R membranes; reverses (R)-α-methylhistamine induced dipsogenia in vivo. Parkinson Disease Phase 1 Clinical |
---|---|
References | References 1. Nirogi R, et al. J Med Chem. 2019 Jan 10. doi: 10.1021/acs.jmedchem.8b01280. View Related Products by Target Histamine Receptor Parkinson Disease |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 562.4±50.0 °C at 760 mmHg |
Molecular Formula | C21H31N3O3 |
Molecular Weight | 373.489 |
Flash Point | 294.0±30.1 °C |
Exact Mass | 373.236542 |
LogP | 2.56 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.597 |